Introduction: Nonvisualization of the fetal gallbladder has been associated with benign conditions such as isolated gallbladder agenesis or severe diseases such as biliary atresia (BA). Recently, gamma-glutamyl transpeptidase (GGTP) fetal blood levels were reported as useful after 22 weeks. Objective: To determine the contribution of fetal blood GGTP levels after 22 weeks, based on 2 cases. Case 1: 20+4-week secundipara, with subcutaneous edema and pleural effusion. At 24+4 weeks, the gallbladder could not be visualized. Progressive hydrops deterioration was observed. 32+2-week magnetic resonance imaging (MRI) confirmed nonvisualization of the gallbladder. BA was suspected. The patient decided to terminate the pregnancy and fetal blood sample was obtained at feticide. GGTP was 573 IU/L. Fetal necropsy confirmed BA. Case 2: At the 22+6- and 24+0-week ultrasound scan, the gallbladder could not be visualized. Amniocentesis was offered, but declined by the patient. MRI at 35+0 weeks failed also to visualize it. Fetal cord blood sample at delivery was obtained, and GGTP was 129 IU/L. Ultrasound confirmed gallbladder agenesis with normal extra- and intrahepatic bile ducts. Conclusion: Cases of nonvisualized gallbladder after 22 weeks have rarely been reported in the literature. Until now, no standard management has been proposed. Our cases support the potential usefulness of fetal blood digestive enzymes.

1.
Blazer S, Zimmer EZ, Bronshtein M: Nonvisualization of the fetal gallbladder in early pregnancy: comparison with clinical outcome. Radiology 2002;224:379-382.
2.
Bronshtein M, Weiner Z, Abramovici H, Filmar S, Erlik Y, Blumenfeld Z: Prenatal diagnosis of gall bladder anomalies - report of 17 cases. Prenat Diagn 1993;13:851-861.
3.
Shen O, Rabinowitz R, Yagel S, Gal M: Absent gallbladder on fetal ultrasound: prenatal findings and postnatal outcome. Ultrasound Obstet Gynecol 2011;37:673-677.
4.
Muller F, Bernard P, Salomon LJ, Dreux S, Allaf B, Czerkiewicz I, et al: Role of fetal blood sampling in cases of non-visualization of fetal gallbladder. Ultrasound Obstet Gynecol 2015;46:743-744.
5.
Bennion RS, Thompson JE, Tompkins RK: Agenesis of the gallbladder without extrahepatic biliary atresia. Arch Surg 1988;123:1257-1260.
6.
Ben-Ami M, Perlitz Y, Shalev S, Shajrawi I, Muller F: Prenatal diagnosis of extrahepatic biliary duct atresia. Prenat Diagn 2002;22:583-585.
7.
Chardot C: Biliary atresia. Orphanet J Rare Dis 2006;1:28.
8.
Green DW, Howard ER, Davenport M: Anaesthesia, perioperative management and outcome of correction of extrahepatic biliary atresia in the infant: a review of 50 cases in the King's College Hospital series. Paediatr Anaesth 2000;10:581-589.
9.
Yoon PW, Bresee JS, Olney RS, James LM, Khoury MJ: Epidemiology of biliary atresia: a population-based study. Pediatrics 1997;99:376-382.
10.
McKiernan PJ, Baker AJ, Kelly DA: The frequency and outcome of biliary atresia in the UK and Ireland. Lancet Lond Engl 2000;355:25-29.
11.
Boughanim M, Benachi A, Dreux S, Delahaye S, Muller F: Nonvisualization of the fetal gallbladder by second-trimester ultrasound scan: strategy of clinical management based on four examples. Prenat Diagn 2008;28:46-48.
12.
Ochshorn Y, Rosner G, Barel D, Bronshtein M, Muller F, Yaron Y: Clinical evaluation of isolated nonvisualized fetal gallbladder. Prenat Diagn 2007;27:699-703.
13.
Dreux S, Boughanim M, Lepinard C, Guichet A, Rival J-M, de Becdelievre A, et al: Relationship of non-visualization of the fetal gallbladder and amniotic fluid digestive enzymes analysis to outcome. Prenat Diagn 2012;32:423-426.
14.
Muller F, Gauthier F, Laurent J, Schmitt M, Boué J: Amniotic fluid GGT and congenital extrahepatic biliary damage. Lancet Lond Engl 1991;337:232-233.
15.
Bardin R, Danon D, Tor R, Mashiach R, Vardimon D, Meizner I: Reference values for gamma-glutamyl-transferase in amniotic fluid in normal pregnancies. Prenat Diagn 2009;29:703-706.
16.
Nonimmune hydrops fetalis - UpToDate [Internet]. [cited November 12, 2016]. Available from: https://www-uptodate-com.proxy1.athensams.net/contents/nonimmune-hydrops-fetalis?source=search_result&search=hydrops&selectedTitle=1~149.
17.
Hertzberg BS, Kliewer MA, Maynor C, McNally PJ, Bowie JD, Kay HH, et al: Nonvisualization of the fetal gallbladder: frequency and prognostic importance. Radiology 1996;199:679-682.
18.
Chalouhi GE, Muller F, Dreux S, Ville Y, Chardot C: Prenatal non-visualization of fetal gallbladder: beware of biliary atresia! Ultrasound Obstet Gynecol 2011;38:237-238; author reply 238-240.
19.
Pérez L, Bequer L, Gómez T, González O, Heredia D, Molina O: Actividad de la gamma glutamil transferasa sérica: distribución estadística, variaciones según edad y sexo e intervalos de referencia en villa clara. ResearchGate 2013;3:122-143.
20.
Bartnicki J, Sledziewski A, Jóźwik M, Urban J: Umbilical cord gamma-glutamyl transpeptidase and placental dysfunction. Int J Gynaecol Obstet 1989;29:31-34.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.